Camille Brazzle, MD
Family Medicine · Okemos, MINPI 1194286484
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,009, 6.4 times the $158 reported in 2021.
Across 19 payments — averaging $109.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$478
- Supernus Pharmaceuticals, Inc.$407
- Axsome Therapeutics, Inc.$353
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$214
- E.r. Squibb & Sons, L.L.C.$181
- Alkermes, Inc.$169
- plus $276 from 3 others
What the payments were for
- Food & beverage$2,078100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $478 |
| Supernus Pharmaceuticals, Inc. | 3 | $407 |
| Axsome Therapeutics, Inc. | 3 | $353 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $214 |
| E.r. Squibb & Sons, L.L.C. | 2 | $181 |
| Alkermes, Inc. | 2 | $169 |
| Teva Pharmaceuticals USA, Inc. | 1 | $135 |
| AbbVie | 1 | $122 |
| Incyte Corporation | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$409
- REXULTI$357
- Auvelity$353
- QELBREE$250
- CAPLYTA$214
- Austedo XR$135
- VRAYLAR$122
- ABILIFY MAINTENA$121
- ABILIFY ASIMTUFII$121
How this compares
$2,078 in reported general payments places this provider in the 80th percentile of 3,945 family medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TradjentaLinagliptin | 16 | $13,348 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $11,899 |
| XareltoRivaroxaban | 11 | $9,680 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 31 | $1,713 |
| Atorvastatin Calcium | 147 | $1,465 |
| Ventolin HfaAlbuterol Sulfate | 14 | $1,400 |
| Ezetimibe | 15 | $1,378 |
| Diclofenac Sodium | 17 | $1,026 |
| Gabapentin | 78 | $911 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 40 | $761 |
| Levothyroxine Sodium | 53 | $699 |
| Mirtazapine | 27 | $622 |
| Baclofen | 17 | $617 |
| CholestyramineCholestyramine (With Sugar) | 14 | $601 |
| Omeprazole | 60 | $572 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Okemos
- Loren ChudlerSouthfield$1.3M
- Paul BensonBerkley$779K
- Matt RosenbergJackson$550K
- Steve LasaterSaint Johns$291K
- Mary DagenGrand Rapids$265K
- Farhan BhattiLansing$230K
- Jeffrey DeitchSterling Heights$197K
- Sukhpreet SinghPlymouth$173K
- James VoigtOak Park$140K
- Timothy IzzoGrand Ledge$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.